Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00611871 · ClinicalTrials.gov registry record · Phase 2
The Use of Propranolol to Block Memory Reconsolidation in PTSD
A Phase 2 study, sponsored by Wayne State University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
NCT00611871 is a Phase 2 study that was terminated before completion, run by Wayne State University. The registered enrollment target is 12 participants.
The verdict
NCT00611871, a Phase 2 study, was terminated before completion, sponsored by Wayne State University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this investigation is to see if propranolol will reduce the psychophysiological hyperactivation associated with memories of combat stress in Veterans with Posttraumatic Stress Disorder.
Interventions
- DRUG Placebo
- DRUG Propranolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2007-09 |
| Est. Completion | 2015-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00611871
The ClinicalTrials.gov registry entry for NCT00611871 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00611871 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00611871 about?
NCT00611871 is a clinical study titled "The Use of Propranolol to Block Memory Reconsolidation in PTSD". The purpose of this investigation is to see if propranolol will reduce the psychophysiological hyperactivation associated with memories of combat stress in Veterans with Posttraumatic Stress Disorder.
What is the current status of trial NCT00611871?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2007-09. Estimated completion is 2015-09.
What interventions are being tested in trial NCT00611871?
The interventions under investigation include: Placebo (DRUG), Propranolol (DRUG).
Who is sponsoring clinical trial NCT00611871?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.